CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) - USD ($) $ in Thousands	Mar. 31, 2022	Jun. 30, 2021
Current Assets:
Cash and cash equivalents	$ 46,010	$ 44,460
Short term investments	32	32
Accounts receivable – net	3,943	4,526
Accounts receivable - related party	30	12
Medical receivable – net	19,548	17,901
Management and other fees receivable – net	32,804	30,948
Management and other fees receivable – related medical practices – net	8,489	7,814
Contract assets	15
Inventories	2,368	1,663
Prepaid expenses and other current assets	1,095	1,227
Total Current Assets	114,334	108,583
Accounts receivable – long term	2,066	2,880
Deferred income tax asset	12,475	15,959
Property and equipment – net	22,441	21,850
Right-of-use Asset – operating lease	34,792	30,133
Right-of-use Asset – financing lease	978	1,127
Goodwill	4,269	4,269
Other intangible assets – net	3,770	4,038
Other assets	524	667
Total Assets	195,649	189,506
Current Liabilities:
Current portion of long-term debt and capital leases	40	173
Accounts payable	1,011	1,866
Other current liabilities	4,916	9,162
Unearned revenue on service contracts	3,869	4,366
Unearned revenue on service contracts – related party	28
Contract liabilities		15
Operating lease liability - current portion	3,733	3,533
Financing lease liability - current portion	208	203
Customer deposits	361	731
Total Current Liabilities	14,166	20,049
Long-Term Liabilities:
Unearned revenue on service contracts	2,035	2,801
Deferred income tax liability	238	238
Due to related medical practices	93	93
Operating lease liability – net of current portion	33,659	28,975
Financing lease liability – net of current portion	892	1,049
Long-term debt and capital leases, less current portion	169	760
Other liabilities	123	171
Total Long-Term Liabilities	37,209	34,087
Total Liabilities	51,375	54,136
STOCKHOLDERS' EQUITY:
Class A non-voting preferred stock $.0001 par value; 453 shares authorized at March 31, 2022 and June 30, 2021, 313 issued and outstanding at March 31, 2022 and June 30, 2021
Preferred stock $.001 par value; 567 shares authorized at March 31, 2022 and June 30, 2021, issued and outstanding – none
Common Stock $.0001 par value; 8,500 shares authorized at March 31, 2022 and June 30, 2021, 6,566 issued at March 31, 2022 and June 30, 2021, 6,554 outstanding at March 31, 2022 and June 30, 2021	1	1
Class B Common Stock (10 votes per share) $.0001 par value; 227 shares authorized at March 31, 2022 and June 30, 2021; .146 issued and outstanding at March 31, 2022 and June 30, 2021
Class C Common Stock (25 votes per share) $.0001 par value; 567 shares authorized at March 31, 2022 and June 30, 2021, 383 issued and outstanding at March 31, 2022 and June 30, 2021
Paid-in capital in excess of par value	184,531	185,101
Accumulated deficit	(35,810)	(46,008)
Treasury stock, at cost - 12 shares of common stock at March 31, 2022 and June 30, 2021	(675)	(675)
Total Fonar Corporation’s Stockholders’ Equity	148,047	138,419
Noncontrolling interests	(3,773)	(3,049)
Total Stockholders' Equity	144,274	135,370
Total Liabilities and Stockholders' Equity	$ 195,649	$ 189,506